» Articles » PMID: 28713338

Investigation of in the Virulence of Using a New Neonatal Mouse Model

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2017 Jul 18
PMID 28713338
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

is an opportunistic human fungal pathogen that poses a serious threat to low birth weight neonates, particularly at intensive care units. In premature infants, the distinct immune responses to infections are not well understood. Although several models exist to study systemic candidiasis, only a few are available to investigate dissemination in newborns. In addition, the majority of related studies apply intraperitoneal infection rather than intravenous inoculation of murine infants that may be less efficient when studying systemic invasion. In this study, we describe a novel and conveniently applicable intravenous neonatal mouse model to monitor systemic infection. Using the currently developed model, we aimed to analyze the pathogenic properties of different strains. We infected 2 days-old BALB/c mouse pups via the external facial vein with different doses of strains. Homogenous dissemination of yeast cells was found in the spleen, kidney, liver and brain of infected newborn mice. Colonization of harvested organs was also confirmed by histological examinations. Fungal burdens in newborn mice showed a difference for two isolates of . CLIB infection resulted in higher colonization of the spleen, kidney and liver of neonatal mice compared to the GA1 strain at day 2 after the infection. In a comprehensive study with the adult mice infection, we also presented the attenuated virulence of a cell wall mutant () in this model. Significantly less / null mutant cells were recovered from the spleen, kidney and liver of newborn mice compared to the wild type strain. When investigating the cytokine response of neonatal mice to infection, we found elevated TNFα, KC, and IL-1β expression levels in all organs examined when compared to the uninfected control. Furthermore, all three measured cytokines showed a significantly elevated expression when newborn mice were infected with / cells compared to the wild type strain. This result further supported the inclusion of in pathogenicity. To our current knowledge, this is the first study that uses a mice neonatal intravenous infection model to investigate infection.

Citing Articles

Transcriptome and proteome profiling reveals complex adaptations of Candida parapsilosis cells assimilating hydroxyaromatic carbon sources.

Cillingova A, Toth R, Mojakova A, Zeman I, Vrzonova R, Sivakova B PLoS Genet. 2022; 18(3):e1009815.

PMID: 35255079 PMC: 8929692. DOI: 10.1371/journal.pgen.1009815.


Role of Protein Glycosylation in Interactions of Medically Relevant Fungi with the Host.

Gomez-Gaviria M, Vargas-Macias A, Garcia-Carnero L, Martinez-Duncker I, Mora-Montes H J Fungi (Basel). 2021; 7(10).

PMID: 34682296 PMC: 8541085. DOI: 10.3390/jof7100875.


Deciphering of induced immune response in .

Csonka K, Tasi Z, Vedelek V, Vagvolgyi C, Sinka R, Gacser A Virulence. 2021; 12(1):2571-2582.

PMID: 34569900 PMC: 8477938. DOI: 10.1080/21505594.2021.1980989.


Serum concentrations of endothelial cell adhesion molecules and their shedding enzymes and early onset sepsis in newborns in Suriname.

Zonneveld R, Jongman R, Juliana A, Molema G, van Meurs M, Plotz F BMJ Paediatr Open. 2018; 2(1):e000312.

PMID: 30397669 PMC: 6203012. DOI: 10.1136/bmjpo-2018-000312.


Impact of Fungal MAPK Pathway Targets on the Cell Wall.

Chow J, Notaro M, Prabhakar A, Free S, Cullen P J Fungi (Basel). 2018; 4(3).

PMID: 30096860 PMC: 6162559. DOI: 10.3390/jof4030093.

References
1.
Toth R, Alonso M, Bain J, Vagvolgyi C, Erwig L, Gacser A . Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response. Front Microbiol. 2015; 6:1102. PMC: 4602145. DOI: 10.3389/fmicb.2015.01102. View

2.
Laffey S, Butler G . Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology (Reading). 2005; 151(Pt 4):1073-1081. DOI: 10.1099/mic.0.27739-0. View

3.
Jong A, Stins M, Huang S, Chen S, Kim K . Traversal of Candida albicans across human blood-brain barrier in vitro. Infect Immun. 2001; 69(7):4536-44. PMC: 98530. DOI: 10.1128/IAI.69.7.4536-4544.2001. View

4.
Castillo L, MacCallum D, Brown A, Gow N, Odds F . Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants. Infect Immun. 2010; 79(1):146-52. PMC: 3019922. DOI: 10.1128/IAI.01004-10. View

5.
Glascock J, Osman E, Coady T, Rose F, Shababi M, Lorson C . Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice. J Vis Exp. 2011; (56). PMC: 3227174. DOI: 10.3791/2968. View